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Abstract 
Cerebrotendinous Xanthomatosis (CTX) is a rare genetically determined error of metabolism. 
The characteristic clinical symptoms are diarrhea, juvenile cataracts, tendon xanthomas and 
neuropsychiatric alterations. The aim of this study is to present a pair of identical adult twins 
with considerable differences in the severity of phenotype. With regards to neuropsychiatric 
symptoms, the predominant features were severe Parkinsonism and moderate cognitive 
dysfunctions in the more affected individual, whereas these alterations in the less affected 
patient were only very mild and mild, respectively. The characteristic increase in the 
concentrations of serum cholestanol and the lesion volumes in dentate nuclei in the brain 
assessed with magnetic resonance imaging were quite similar in both cases. The lifestyle 
conditions, including eating habits of the twin pair, were quite similar as well, therefore 
currently unknown genetic modifiers or certain epigenetic factors may be responsible for the 
differences in severity of phenotype. This case series serves as the first description of an 
identical twin pair with CTX presenting heterogeneous clinical features. 
Keywords: Cerebrotendinous Xanthomatosis, Parkinsonism, cognitive dysfunction, identical 
twins, heterogeneous phenotype 
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Introduction 
Cerebrotendinous Xanthomatosis (CTX) is an autosomal recessively inherited condition 
belonging to the group of inborn errors of metabolism [1]. It affects approximately 1 to 2 out 
of 100,000 individuals. The pathogenic mutations are located in the CYP27A1 gene mapped 
to 2q35 [2,3]. The gene product, sterol 27-hydroxylase, which is expressed in the central 
nervous system, liver, lungs, duodenum and endothelial cells, takes part in the appropriate 
production of bile acids from cholesterol [4]. Sterol 27-hydroxylase deficiency results in the 
accumulation of 7α-hydroxy-4-cholesten-3-one and its metabolites, including cholestanol, and 
also results in the insufficient production of chenodeoxycholic acid [1]. The main 
characteristic signs and symptoms of CTX are diarrhea, juvenile cataracts, tendon xanthomas 
and neuropsychiatric alterations, including cognitive and psychiatric disturbances, pyramidal 
and/or cerebellar signs, seizures and Parkinsonism [3]. Although there is a marked 
heterogeneity of signs and symptoms in CTX patients, even in intrafamilial cases [2], no 
phenotypic variability has yet been reported in twins or triplets, [5]. The aim of the current 
study is to present the considerably different phenotypes of a pair of identical adult twins 
diagnosed with CTX. 
 
Case reports 
One member of a 40-year-old female twin pair was first admitted to our neurology department 
in 2016 with the aim of a diagnostic work-up on her movement disorder. She had already had 
cataracts and glaucoma in childhood, but her movement and speech only began to worsen 
progressively from 2013. Additionally, she complained of an episode of pronounced diarrhea 
and gastrointestinal discomfort in 2015, and her parents mentioned memory problems, anxiety 
and impatience as well. On neurological examination, she presented signs of a movement 
disorder with dominating Parkinsonism (moderate symmetric hypo- and bradykinesia, rigor, 
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mainly right-sided occasional limb rest tremor, severe postural instability, freezing of gait, 
antecollis, hypomimia, severe dysarthria and mild seborrhea; Movement Disorder Society 
Unified Parkinson’s Disease Rating Scale (MDS-UPDRS) part III: 75 points in OFF state; 
Suppl. video 1) showing some levodopa response (MDS-UPDRS part III: 56 points in ON 
state, i.e., 25.3% improvement; Suppl. video 2). Furthermore, the patient had mild cerebellar 
ataxia and pyramidal signs (brisk patellar reflex and ankle clonus on the right side with 
bilateral Babinski sign) as well. The unaided stance and gait could not be implemented. The 
neuropsychological assessment demonstrated moderate cognitive dysfunctions in light of 
65/100 points in Addenbrooke’s Cognitive Examination (ACE) and 24/30 points in the Mini-
Mental State Examination (MMSE). The skull MRI revealed T2 and FLAIR abnormal signals 
in the dentate nuclei and some supratentorial white matter alterations (Figures 1A, B, C and 
D). The clinical picture raised the possibility of CTX which was supported by elevated serum 
cholestanol levels (31 µM; normal range: 2-12.6 µM). The genetic testing for a disease-
causing mutation in the CYP27A1 gene revealed a known pathogenic homozygous frameshift 
mutation in exon 4 (c.819delT, p.D273EfsTer13). 
With regards to family history, the other member of the twin pair also had juvenile cataracts 
and glaucoma and was suspected to have some kind of immunological disorder. Furthermore, 
her parents also reported less expressed memory problems, anxiety and impatience. 
Otherwise, the family history of the assessed patient was irrelevant. Despite the absence of 
pronounced neurological features, this second patient was also screened for possible signs of 
CTX. The examination revealed signs of slight Parkinsonism (mainly left-sided slight hypo- 
and bradykinesia and rigor on provocation in the left upper limb, and moderate postural 
instability; MDS-UPDRS part III: 8 points in OFF state; Suppl. video 3) and mild sensory 
ataxia with a slightly broad-based gait. With regards to cognitive function, the 
neuropsychological assessment demonstrated mild alterations in light of 72/100 points in 
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ACE and 27/30 points in the MMSE. The abnormal signals in the dentate nuclei were present 
as well (Figures 1E and F). Furthermore, the MRI revealed asymptomatic mega cisterna 
magna (Figures 1E, F and H) and a small tentorial meningeoma (Figures 1G and H). Despite 
the less expressed clinical alterations when compared to her twin sister, similarly elevated 
serum cholestanol levels were detected (36.8 µM). The genetic testing identified the same 
disease-causing mutation in the CYP27A1 gene. 
The considerably different phenotypes raised the question of whether the twin pair is identical 
or not. The following 15 short tandem repeat markers were analyzed for that purpose: 
D8S1179, D21S11, D7S820, CSF1PO, D3S1358, TC11, D13S317, D16S539, D2S1338, 
D19S433, VWA, TPOX, D18S51, D5S818 and FGA. The DNA profile of the 2 subjects was 
completely identical, so they are confirmed to be identical twins. The parents were 
heterozygous for the assessed mutation and they did not show any sign or symptom of CTX. 
 
Discussion 
Although the role of CYP27A1 gene mutations in the pathogenesis of CTX is well-
established, no genotype-phenotype correlation can be determined. When compared with 
previously reported CTX patients, the clinical features of our identical twin pair were slightly 
different from typical cases (including those with the same pathogenic mutation [6]), lacking 
tendon xanthomas and seizures, and presenting a predominant Parkinsonian syndrome, 
especially in the more severely affected patient. However, the Parkinsonian features were 
similar to that of a previously published case [7]. Nevertheless, the major aim of this case 
series is not only the simple demonstration of signs and symptoms in this identical twin pair, 
but to draw attention to the considerable differences in the severity of their clinical features 
and the identification of possible underlying factors. Biochemical testing revealed similar 
alterations in cholestanol concentrations, but it is known that the levels of this metabolite have 
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no correlation with clinical phenomena [8]. Although the role of environmental factors has 
been suggested to be possibly responsible for the clinical differences [2], the fact that our twin 
pair has been continuously living together with their parents and their eating habits are similar 
as well, makes this theory questionable. However, currently unknown genetic modifiers of 
certain epigenetic factors may play a role in clinical heterogeneity. The clarification needs 
further studies. 
In conclusion this case series study serves as the first report of identical twins diagnosed with 
CTX demonstrating remarkably different phenotypes. 
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Written informed consent was obtained from the patients for video recording and the 
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Figure Legend 
Figure 1. The main characteristic magnetic resonance imaging (1.5 Tesla) features of our 
patients with Cerebrotendinous Xanthomatosis. The lesion of the dentate nuclei is prominent 
in the more affected member (black arrows; T2-wheighted images: A; FLAIR images: B) and 
the less affected member (black arrows; T2-wheighted images: E; FLAIR images: F) of the 
identical twin pair. Furthermore, the more affected member demonstrated supratentorial white 
matter alterations (black arrows; T2-wheighted images: C; FLAIR images: D). In the less 
affected member the MRI revealed asymptomatic mega cisterna magna (grey arrows; axial 
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T2-wheighted images: E; axial FLAIR images: F; coronal T1-wheighted images: H) and a 
small contrast-enhancing tentorial meningeoma (black arrows; sagittal T1-wheighted images: 
G; coronal T1-wheighted images: H) 
 
Video legends for supplementary materials 
Supplementary video 1. The Parkinsonian features of the more affected member of the 
identical twin pair in OFF state. 
Supplementary video 2. The Parkinsonian features of the more affected member of the 
identical twin pair in ON state following levodopa challenge. 
Supplementary video 3. The very slight Parkinsonian features of the less affected member of 
the identical twin pair. 
 
Figure 1 Click here to download Figure Fig1.tif 
